肝素誘導(dǎo)性血小板減少癥相關(guān)研究進(jìn)展
發(fā)布時(shí)間：2018-11-01 18:54
【摘要】：肝素誘導(dǎo)性血小板減少癥(HIT)是一種少見的危急性、免疫性普通肝素或低分子肝素引起的并發(fā)癥。HIT在接受肝素治療患者中的發(fā)病率為0.6%~5%,尤其是對(duì)心血管手術(shù)或介入治療患者危害很大,是目前臨床研究熱點(diǎn)。本文就HIT發(fā)病機(jī)制、流行病學(xué)、臨床評(píng)估和治療等方面研究進(jìn)展作一簡(jiǎn)要綜述。
[Abstract]:Heparin-induced thrombocytopenia (HIT) is a rare and critical complication caused by immune heparin or low-molecular-weight heparin. The incidence of HIT in patients receiving heparin therapy is 0.6%. Especially for cardiovascular surgery or interventional therapy patients are very harmful, is the current focus of clinical research. This article reviews the pathogenesis, epidemiology, clinical evaluation and treatment of HIT.
【作者單位】： 上海交通大學(xué)附屬第六人民醫(yī)院放射介入科;解放軍第85醫(yī)院放射科;
【分類號(hào)】：R558.2
本文編號(hào)：2304800
[Abstract]:Heparin-induced thrombocytopenia (HIT) is a rare and critical complication caused by immune heparin or low-molecular-weight heparin. The incidence of HIT in patients receiving heparin therapy is 0.6%. Especially for cardiovascular surgery or interventional therapy patients are very harmful, is the current focus of clinical research. This article reviews the pathogenesis, epidemiology, clinical evaluation and treatment of HIT.
【作者單位】： 上海交通大學(xué)附屬第六人民醫(yī)院放射介入科;解放軍第85醫(yī)院放射科;
【分類號(hào)】：R558.2
【相似文獻(xiàn)】
相關(guān)期刊論文 前2條
1 陳興峰;丁紹平;何明;徐安訪;;起搏器介導(dǎo)性心律失常的臨床影響因素分析[J];心血管病防治知識(shí)(學(xué)術(shù)版);2014年05期
2 ;[J];;年期
，本文編號(hào)：2304800
本文鏈接：http://sikaile.net/yixuelunwen/xxg/2304800.html
最近更新
教材專著
